The LACE+ index as a predictor of 30-day patient outcomes in a urologic surgery population: A coarsened exact match study
Urology Oct 11, 2019
Glauser G, Winter E, Caplan IF, et al. - Seven hundred and twenty-two individuals were matched for Q1-Q4, 1,120 for Q2-Q4 and 2,550 for Q3-Q4 in order to investigate the potential of LACE+ scores, in patients who underwent urologic surgery, to prognosticate short-term unwanted outcomes. Raising LACE+ score significantly prognosticated extended readmission and Emergency Room (ER) visits at 30 days postop. Within 30 days, the heightening LACE score did not prognosticate reoperation or within 30 postoperative days, rate of death over follow-up. Hence, the results of this study propose that in a urologic surgery population including unanticipated readmission and ER assessment, the LACE+ index is fit to be a prediction model for superior patient outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries